RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ensysce Biosciences Stock

Ensysce Biosciences Equity 2025

Ensysce Biosciences Equity

3.71 M USD

Ticker

ENSC

ISIN

US2936025046

In 2025, Ensysce Biosciences's equity was 3.71 M USD, a -1,259.38% increase from the -319,999.99 USD equity in the previous year.

Ensysce Biosciences Aktienanalyse

What does Ensysce Biosciences do?

Ensysce Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Ensysce Biosciences's Equity

Ensysce Biosciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ensysce Biosciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Ensysce Biosciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Ensysce Biosciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Ensysce Biosciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Ensysce Biosciences stock

What is the equity of Ensysce Biosciences this year?

Ensysce Biosciences has equity of 3.71 M USD this year.

What was the equity of Ensysce Biosciences compared to the previous year?

The equity of Ensysce Biosciences has increased/decreased by -1,259.38% decreased compared to the previous year.

What impact does a high equity have on investors of Ensysce Biosciences?

A high equity is advantageous for investors of Ensysce Biosciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Ensysce Biosciences?

A low equity can be a risk for investors of Ensysce Biosciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Ensysce Biosciences affect the company?

An increase in equity of Ensysce Biosciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Ensysce Biosciences affect the company?

A reduction in equity of Ensysce Biosciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Ensysce Biosciences?

Some factors that can affect the equity of Ensysce Biosciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Ensysce Biosciences so important for investors?

The equity of Ensysce Biosciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Ensysce Biosciences take to change the equity?

To change equity, Ensysce Biosciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Ensysce Biosciences pay?

Over the past 12 months, Ensysce Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ensysce Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Ensysce Biosciences?

The current dividend yield of Ensysce Biosciences is .

When does Ensysce Biosciences pay dividends?

Ensysce Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ensysce Biosciences?

Ensysce Biosciences paid dividends every year for the past 0 years.

What is the dividend of Ensysce Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ensysce Biosciences located?

Ensysce Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ensysce Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ensysce Biosciences from 5/12/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/12/2025.

When did Ensysce Biosciences pay the last dividend?

The last dividend was paid out on 5/12/2025.

What was the dividend of Ensysce Biosciences in the year 2024?

In the year 2024, Ensysce Biosciences distributed 0 USD as dividends.

In which currency does Ensysce Biosciences pay out the dividend?

The dividends of Ensysce Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ensysce Biosciences

Our stock analysis for Ensysce Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ensysce Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.